QualityStocks News Alert
  The QualityStocks Daily Newsletter for Monday July 27th, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Penny Stock Finder (WMDA)


Hot OTC.com (CBIS)


OTC Picks (HTDS)

The QualityStocks Daily

MagneGas Corporation (MNGA)

Market Pulse reported recently on MagneGas Corporation (MNGA), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MagneGas Corporation is the producer of MagneGas™, a natural gas alternative and metal cutting fuel made from liquid waste. This waste includes sewage, sludge, manure, and certain industrial and oil based liquid wastes. With their corporate headquarters in Palm Harbor, Florida, MagneGas Corporation trades on the OTCBB.

The Company's patented Plasma Arc Flow™ process gasifies liquid waste, creating a clean burning fuel that is essentially interchangeable with natural gas. However, it has lower green house gas emissions. The Plasma Arc Flow™ process gasifies liquid wastes into usable byproducts. These byproducts include the aforementioned MagneGas™, heat, carbon precipitates, and sterile effluent liquid that is under development for organic liquid fertilizer or irrigation water.  MagneGas™ can find use for metal cutting, cooking, heating, or powering bi fuel automobiles.

The Company custom builds recyclers to the specifications of their customers. Products range from a 50KW unit that produces MagneGas for a metal cutting shop up to a 1-megawatt plant capable of processing various liquid wastes in high volume. "Total" mode recyclers for the processing of oil based liquid waste and the maximization of fuel production are available in different configurations through direct sales. MagneGas Corporation owns and licenses the intellectual property for the MagneGas Technology for the territories of North, South, and Central America.

In May, MagneGas Corporation announced that they secured their first equipment purchase order. MagneGas is scheduled to receive a total of $1.2 million in exchange for a proprietary MagneGas Plasma Arc Flow™ refinery. The intention is for it to service immediately the Philippines and Vietnam markets. MagneGas entered into a Memorandum of Understanding on May 18, 2009, and has already received a $100,000 deposit from purchaser American Investment Co.

Earlier this month, The Company secured signed Asset Purchase and Distribution Agreements for the $1.2 million equipment purchase order and subsequent launch of the Philippines and Vietnam markets. These Agreements now solidify that business and the remaining payments timeline. Also earlier this month, MagneGas Corporation announced that they were featured in the Tampa Bay Business Journal (www.tampabay.bizjournals.com).

MagneGas Corporation (MNGA) closed today at $0.37 up $0.17 or 85.00 percent. Volume was 6,980 for a 3-month average volume of 25,530.

GTC Biotherapeutics Inc. (GTCB)

Greenbackers reported recently on GTC Biotherapeutics Inc. (GTCB), and we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ Capital Market, GTC Biotherapeutics Inc. develops, supplies, and commercializes therapeutic proteins produced through transgenic animal technology. Headquartered in Framingham, Massachusetts the Company's ATryn®, a recombinant human antithrombin, has received approval for use in the United States and Europe. ATryn® is the first and only product produced in transgenic animals to be approved for therapeutic use anywhere in the world. GTC Biotherapeutics Inc. is part of the Biotechnology Industry in the Healthcare sector.

ATryn® (Antithrombin [Recombinant]) received approval in Europe for the prophylactic treatment of deep vein thrombosis in patients with hereditary antithrombin deficiencies that are undergoing surgical procedures. ATryn® is produced in the milk of goats developed using microinjection technology to incorporate a human antithrombin transgene.

GTC is also developing a portfolio of recombinant human plasma proteins with known therapeutic properties. These include recombinant forms of human coagulation factors VIIa, VIII, and IX. These find use for the treatment of hemophilia, and alpha-1 antitrypsin. GTC is also developing a portfolio of follow-on biologic monoclonal antibodies and a CD20 antibody with enhanced ADCC (antibody-dependent cell-mediated cytotoxicity).

The Company's intellectual property includes a U.S. patent through 2021 for the production of any therapeutic protein in the milk of any transgenic mammal. Their transgenic production platform is suited to enabling cost effective development of proteins that are difficult to express in traditional recombinant production systems. Their platform is also suited to enabling cost effective development of proteins that are required in large volumes.

Earlier this month, GTC Biotherapeutics, Inc. announced that they obtained exclusive worldwide rights to the development and commercialization of recombinant human alpha-fetoprotein (rhAFP). This includes the recombinant, non-glycosylated version of rhAFP known as MM-093, for the treatment of autoimmune diseases from Merrimack Pharmaceuticals. GTC will receive an initial inventory of bulk drug substance suitable for use in clinical studies. The Company will assume control of the transgenic goats that express rhAFP in their milk, which were originally developed by GTC for Merrimack and are cared for in GTC's facilities. GTC intends to develop further rhAFP through commercial collaborating.

GTC Biotherapeutics Inc. (GTCB) closed Monday's trading session at $2.228 up $0.058 or 2.67 percent. Volume was 15,857 for a 3-month average volume of 46,291.

MedClean Technologies, Inc. (MCLN)

We are highlighting MedClean Technologies, Inc. (MCLN), here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, MedClean Technologies, Inc. is a designer and manufacturer of onsite regulated medical waste (RMW) processing systems and related services. Founded in 1997, the Company's mission is to offer technologically superior solutions for processing RMW. The result of their efforts is The MedClean® System. MedClean Technologies, Inc. has their corporate headquarters in Bethel, Connecticut.

The Company's MedClean System is a state-of-the-art solution for medical waste treatment and disposal. The fully integrated system includes easy-to-handle RMW transportation carts. These safely move medical waste from patient floors in a "one-touch" process that minimizes staff exposure. The system includes a digitally controlled steam autoclave that sterilizes the waste to ensure best-in-industry regulatory compliance. In addition, the system includes a proprietary shredding unit. It reduces the treated waste to safe and unrecognizable mulch suitable for municipal waste disposal.

The Company's process is identical for the container and mobile series. The MedClean Container Series offers easy to implement configurations available in numerous models. This is to accommodate combinations of components and capabilities, and a variety of site logistics. Designed for delivery in specially engineered standard-sized shipping containers, they are easy to place into position at dock or grade level. They allow for straightforward access to utilities via umbilical connections.
The Company's MedClean Mobile Series combines the power of containerized solutions with transportability. These models are especially suitable for multi-site healthcare organizations that prefer to utilize the system across several locations as a shared service to optimize investments and increase savings. MedClean Technologies Inc. also does fixed installations. These are custom designs that fit within healthcare institutions' physical facilities. The Company provides MedClean series systems as solutions to incineration or off site hauling of untreated medical waste, and to various other alternative treatment technologies and methodologies.

MedClean Technologies, Inc. (MCLN) closed today's trading session at $0.0012 up $0.0001 or 9.09 percent. Volume was 54,400.

Skinvisible Inc. (SKVI)

Today, Stock Guru reported on Skinvisible Inc. (SKVI), and we are as well, here at the QualityStocks Daily Newsletter.

Skinvisible Inc. engages in the development and manufacture of topical polymer-based delivery system technologies and formulations for combining hydrophilic and hydrophobic polymer emulsions. They design these to enhance significantly product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic, and skincare products. Skinvisible Inc. trades on NASDAQ's OTCBB and they have their headquarters in Las Vegas, Nevada. They operate together with their subsidiary Skinvisible Pharmaceuticals, Inc.

The Company's corporate objectives are to capitalize on licensing opportunities for their Invisicare technology and formulated products. This is to established pharmaceutical, medical, cosmetic, skincare, and consumer goods manufacturers. They are also working to develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.

Skinvisible Inc. is also directing their efforts to enter into strategic relationships and attract alliances to expand research, development, and collaborative product investigations for their patented polymer delivery vehicles and formulations. In addition, they are working to increase on-going revenues and profitability from current licensees.

Invisicare is a technology for topical and mucosal products, which binds ingredients to the skin and enhances their delivery. The key to Skinvisible's patented technology and trademarked Invisicare family of polymer delivery vehicles is their formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions.

The Company's polymer delivery vehicles allow normal skin respiration and perspiration, which are used in antimicrobial hand sanitizer lotions, sun care products, skincare moisturizers, and sunless tanning products. They are also used in various dermatology products for different skin disorders. Skinvisible Inc. also provides antibacterial/antimicrobial hand sanitizer formulations that offer skincare solutions. These are for the healthcare, food service, industrial, cosmetic, and salon industries, as well as for personal use in the retail marketplace.

Skinvisible, Inc. previously announced that DermSafe, the Company's hand sanitizing lotion, has been proven effective in killing the H1N1 virus. The studies were conducted by Retroscreen Virology of London, England, demonstrating a greater than 99.99 percent inactivation/kill on the H1N1 influenza A virus. The spread of this virus has increased the Company's efforts in the global licensing of DermSafe. Skinvisible has been working with potential licensees for DermSafe in the United States, Canada, China, Hong Kong, Singapore, and other parts of Southeast Asia, Japan, the United Kingdom, Europe, Australia, Africa, and Mexico.

Skinvisible Inc. (SKVI) closed Monday's trading at $0.13 up $0.05 or 62.50 percent. Volume was 958,847 for a 3-month average of 79,720.

Gulf Alternative Energy Corporation (GAEC)

Today we highlight Gulf Alternative Energy Corporation (GAEC) as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Gulf Alternative Energy Corporation is an alternative energy company focused on the development of the alternative energy industry with a particular emphasis on Texas and the Gulf Coast. Trading on the Pink Sheets, the Company's mission is to provide technology to the ethanol industry to increase production efficiencies and lower the cost of renewable energy. They are working on developing cellulosic ethanol production technologies. Gulf Alternative Energy Corporation has their headquarters in Houston, Texas.

The Company's team has extensive experience in the petroleum industry, trading and exchange industries, as well as in wholesale marketing and international trade. They are applying this expertise and experience to the ethanol industry. Ethanol is a fuel oxygenate.  Added to gasoline, oxygenates increase the amount of oxygen in the gasoline blend, and improves the air quality characteristics of its emissions. Ethanol also has potential for fuel cell technologies. Gulf Alternative Energy Corporation primarily sources ethanol from sugary crops, such as sugarcane.

The Company's new technology delivers faster processing of cellulose into sugars. Lab tests show that their pre-processing technology produces tiny 10-micron particles of cellulosic material that process into sugars 400 percent faster than the control samples. Gulf is positioning their Company to be an integrated part of the growing new energy future. They believe that effective pre-processing unlocks the key to effective cellulosic ethanol.

On July 13, 2009, Gulf Alternative Energy Corporation announced today the lab test results on their biomass pre-processing technology. This process converts cellulosic biomass into a fine, dry powder for processing into ethanol. Testing was conducted by the Microbac Laboratories, Inc. in Boulder, Colorado. Lab results showed that all sugars were produced from Gulf Sorghum in 16 hours compared to 64 hours for unprocessed control samples. This represents a 400 percent increase in processing speed under controlled lab conditions. Microbac concluded that Gulf’s industrial grade processing was as efficient as the best lab scale processing used to test biomass.

We're tracking Gulf Alternative Energy Corporation (GAEC) on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Today, Gulf Alternative Energy Corporation (GAEC) closed at $1.40 down $0.15 or 9.68 percent. Volume was 49,069.

CMG Holdings, Inc. (CMGO)

Today we are highlighting CMG Holdings, Inc. (CMGO) as "One to Watch", here at the QualityStocks Daily Newsletter.

CMG Holdings, Inc. is a full service global marketing, sports, entertainment, and management communications company. Trading on the OTCBB, the company operates in the sectors of talent management, event management, and commercial rights. CMG Holdings, Inc. has an office in New York, New York and an office in Miami, Florida.

The company’s Talent Management division includes representation of personalities in the entertainment, athletic, and literary industries. This is for endorsements, licensing, speaking appearances, and image marketing. CMG Holdings’ Event Management services include marquis hospitality, sponsorships, licensing, production, and implementation of events. This includes hospitality services pairing corporate client sponsors and premier events to ensure the highest return on their investment and brand exposure. In addition, the company’s Commercial Rights includes branding, consulting, licensing, sponsorships, and sales through image marketing tools to generate premier brand recognition for their clients.

Last month, CMG Holdings, Inc. announced that their wholly owned subsidiary completed the formation of a joint venture to create an internet broadcast music channel. The joint venture entity, 24HVC, LLC will transmit music content through an internet broadcast channel. The 24 Hour Video Channel™ (24HVC) will deliver live music performances, on-demand videos, and other music entertainment content. They will do this in a high definition video and audio format.

Also in June, CMG Holdings, Inc. announced that XA produced the Chicago Special Screening of Universal Pictures’ “Public Enemies” in Chicago. The company’s XA, The Experiential Agency, Inc. subsidiary has offices in Chicago, New York, and Los Angeles. XA provides corporations and highly visible brands with comprehensive event marketing, design, and production services. The XA brand has a 20-year history. Their team has been the creative force behind national projects for clients including NBC Universal, UNICEF, Harrah’s Entertainment, Conde Nast, McDonalds, W Hotels, Emirates Airline, and Ritz Carlton.

We're keeping our eye on CMG Holdings, Inc. (CMGO) and tracking them on our radar screens as "One to Watch", here at the QualityStocks Daily Newsletter.

CMG Holdings, Inc. (CMGO) closed today's session at $0.06 on no volume. The 3-month average is 9,963.

Iris BioTechnologies Inc. (IRSB)

Today we highlight Iris BioTechnologies Inc. (IRSB), here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Iris BioTechnologies Inc.'s commitment is to the development of Nano-Biochip gene expression kits to assist in establishing a solid and reliable foundation for personalized medicine. The Company developed their patented products to overcome the sensitivity, specificity, speed, and cost limitations of current state-of-the-art microarray technology. They designed their Iris products to be FDA approved, enabling them to be used in any certified laboratory globally. Iris BioTechnologies Inc. started in 1999 through the efforts of their Founder and CEO, Simon Chin. Iris BioTechnologies Inc. has their corporate headquarters in Santa Clara, California. They have an operations office in San Leandro, California.

The Company developed their first biochip to identify gene expression patterns in the multiple varieties of breast cancer. They are working in this area because they perceive an acute need for a robust staging classification system. They also see a need for more effective predictive and prognostic tools to assist in medical treatment decisions. They designed their Nano-Biochip and BioWindows™ informatics program to enable a treating physician to prescribe quickly a personalized treatment regimen that will have the greatest probability of success for each individual patient's particular form of breast cancer.

The Company has multiple patents, cost-effective parallel processing technologies, and key business relationships in the United States, Europe, and Asia.  Iris BioTechnologies is in a position now to launch their first product, a BreastCancerChip™. Other Chips in the Company's pipeline will include the Human Organ Transplant (HOT™) Chip, NeuroChip™, CardioChip™, and MetabolicChip™ for human use. They will also include specialized and proprietary chips for veterinary, agricultural, and environmental applications. The Company expects further growth for drug development, stem cell research, and evolving clinical applications from growth in their proprietary analytical BioWindows™ database.

Iris BioTechnologies Inc. (IRSB) closed today's trading session at $0.95 up $0.49 or 106.52 percent. Volume was 100 shares for a 3-month average of 658 shares.

AuraSound, Inc. (ARAU)

OTC Picks, Penny Invest, and StockEgg.com reported earlier on AuraSound, Inc. (ARAU), and we highlight the Company, here at the QualityStocks Daily Newsletter.

AuraSound, Inc. engages in the development, commercialization, and sale of audio products, sound systems, and audio components using their patented and proprietary electromagnetic technology. As an audio company, they specialize in the production of high SPL, bass-rich, low distortion sound from compact transducers. AuraSound owns, manufactures, and sells products based on proprietary NRT® Drivers, BassShakers™, and Line Source™ tweeters.

Founded in 1987, AuraSound, Inc., formerly known as Hemcure, Inc., operates as a subsidiary of Algo Technology, Inc.  AuraSound was acquired December 1, 1999 by Algo Technology, Inc. Algo specializes in the manufacturing, distribution, and sale of products for the multimedia and entertainment markets. In addition to Algo Sound, Inc. (dba AuraSound, Inc.), Algo's other two subsidiaries are Alaris, Inc. and Regaltronic, Ltd.

AuraSound, Inc.'s principal markets are Mobile Audio and Home Theater for speaker systems and amplifiers, the OEM audio market for proprietary drivers, and the OEM gaming and arcade market for patented, inverted voice coil and tactile transducers. The Company is an OEM Speaker Drivers Supplier to major computer, TV, arcade, and multimedia companies. AuraSound also offers Mobile Reference, RPM, and Force Series Speakers, Amplifiers and Subwoofers. The company is expanding into the micro-audio market. They have developed, patented and are marketing undersized speakers that deliver sound quality to devices such as laptops, flat-panel televisions, displays and mobile phones.

AuraSound conducted extensive research and development in magnetics and materials sciences. This resulted in their Neo-Radial Technology (NRT), drivers, and a unique teardrop-shaped motor structure that offers an unconventional design, efficiency, and performance. NRT delivers large excursion capabilities, increased linearity, greater power handling, and lower distortion. The NRT speaker can handle large amounts of power with minimal power compression.  Aura currently has 55 patents issued and allowed, and 75 patents pending.

AuraSound, Inc. (ARAU) closed today's trading at $0.10 up $0.05 or 100.00 percent. Volume was 9,000.

The QualityStocks Company Corner

Savoy Energy Corp. (SNVP)
Axial Vector Energy Corp. (AXVC)
Suspect Detection (SDSS)

Consorteum Holding (CSRH)BLOG
Sector 10 Inc. (SECI) BLOG
CytRx Corp. (CYTR) BLOG

eDOORWAYS Corporation (EDWY)

The QualityStocks Daily Newsletter would like to spotlight eDOORWAYS Corporation (EDWY) Today, eDOORWAYS Corp. closed trading at $0.024, which was up $0.001 or 2.13 percent. Their volume today was 1,571,895 shares.

Today, eDOORWAYS Corporation provided an update concerning Status Reports, Filings, and its Pre-Launch Presentation.

eDOORWAYS Corp. is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. The company has the potential to completely change the future landscape of business by offering a unique and comprehensive service that saves consumers valuable time and money. By uniting a consumer with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes “dynamic” commerce, as opposed to the static model currently in existence.

The Company plans to capitalize on several emerging new trends. These newly created opportunities include: the large success of Web 2.0 Internet community service offerings such as MySpace, the movement towards niche marketing and targeted advertising, the introduction of new technologies that enable instantaneous, online presentation of information, and the rising consumer preference for using the Internet to gain information before making purchasing decisions.

eDOORWAYS plans to introduce local services using a city-by-city strategy that will minimize capital requirements, reduce staffing requirements, and optimize generated revenues. Ten major cities are targeted for launch in the first year. Advertising, PR campaigns and viral word-of-mouth will be used to give a public presentation to experts as well as educate the market.

The key benefits offered to consumers include a higher level of engagement with vendors, trusted information from other consumers, and superior customer service. Revenues will be generated through advertising placement fees, premium services, preferential placement fees, and a percentage of sales transactions. eDOORWAYS' progressive vision and professional management team makes it an attractive investment opportunity. Disclaimer

Savoy Energy Corp. (SNVP)

The QualityStocks Daily Newsletter would like to spotlight Savoy Energy Corp. (SNVP). Today, Savoy Energy Corp. closed trading at $0.415, which was up $0.06 or 16.90 percent. Their volume today was 37,064 shares.

Savoy Energy Corp. (SNVP) an independent oil and gas company, is focused on building a diversified portfolio of valuable oil and gas assets in the United States. Incorporated in 1982, the company’s business model is to identify abandoned oil and gas assets, which are then brought online through recompletion and work-over activities, a meticulous process of evaluation, application of modern well technology, and stringent management controls.

The company’s officers, directors and geologists together retain more than a century of experience in the oil and gas industry. The management team is focused on strategically increasing Savoy Energy’s asset base and cash flow, while significantly reducing the cost of initial drilling, effectively reducing the risk of traditional exploration projects. Furthermore, the company’s financial structure allows it to minimize the high overhead of traditional E&P companies.

Today, it’s a distinct financial advantage to be a small company looking for small abandoned properties for acquisition. Larger companies, as well as most mid-size companies, are searching for large acquisitions and new drilling to successfully increase the size of their company. However, large acquisitions are expensive and the cost of drilling can prolong the return on investment. Furthermore, large plays are difficult to locate, encouraging most companies to look outside U.S. borders.

Since inception, Savoy Energy has successfully owned or participated in more than 100 wells in Texas, Oklahoma, and Ohio. Currently, the company leases four properties in Gonzales County, Texas. These properties include: Wright, 485.41 acres; Rozella Kifer, 193.003 acres; Ali-O No.1, 82.66 acres; and Zavadil No.1, 45 acres. Savoy Energy’s phased approach is to concentrate on existing low maintenance production, exploit low risk sidetrack drilling opportunities as identified through day to day research, and use the accumulated information and results to advance operations. Disclaimer

Savoy Energy Corp. Blog

Savoy Energy Corp. News:

Savoy Energy Meets With Minister of Lands & Mineral Resources

Savoy Energy Appoints New Board Members with International Oil Exploration Experience

Stock-Pr.com Announces Alerts on TEGR, SNVP

Axial Vector Energy Corporation (AXVC)

The QualityStocks Daily Newsletter would like to spotlight Axial Vector Energy Corp. (AXVC). Today, Axial Vector Energy Corp. closed trading at $0.16, which was down $0.01 or 5.88 percent. Their volume today was 161,925 shares. Their 3-month average volume is 149,286.

Axial Vector Energy Corporation (AXVC) a publicly traded, development-stage company providing global energy solutions, develops multi-fuel engines and generators for use primarily in military and commercial applications.

Founded in 2002, with headquarters in Portland, Oregon, Axial Vector - through a joint venture agreement with Adaptive Propulsion Systems, LLC - develops and manufactures their engines and generators with an eye towardenvironmental responsibility and social benefit.

Axial Vector Energy Corporation (AXVC) owns, develops and licenses a technologically advanced suite of internal combustion engines and electric power generation modules. The company has also developed the world's only "coreless" no iron electric motors, which consume one half the electricity of conventional electric motors.

These cutting-edge technologies are focused on fulfilling global engine and energy needs by delivering greater fuel-efficiency, cost effectiveness, versatility, and environmental sensitivity than ever before in venues from the commercial to the industrial, including the vehicular and military sectors.Disclaimer

Axial Vector Energy Corporation Blog

Axial Vector Energy Corporation News:

Axial Vector Energy Corporation Announces Successful Demonstration of Engine Running Non-Fossil Fuel

AVEC Updates Global Investment Community on July 14th Technology Presentation

Global Operations to Serve as Advisor to AVEC

Suspect Detection Systems, Inc. (SDSS)

The QualityStocks Daily Newsletter would like to spotlight Suspect Detection Systems Inc. (SDSS). Today Suspect Detection Systems, Inc. closed trading at $0.14, which was down $0.02 or 13.04 percent. Their volume today was 114,279 shares.

Suspect Detection Systems Inc. (SDSS) announced the introduction of a new commercial product, the Cogito Data Center (Cogito DC). Cogito DC is a central knowledgebase and control server that serves as a complete analytical back office to the Cogito Rapid Interrogation System. The first sales of the Cogito DC unit are expected in 2010.

Suspect Detection Systems Inc. (SDSS) has dedicated its efforts to developing innovative Homeland Security, Military Intelligence and Law Enforcement advance technologies based on extensive intelligence and counter-terrorism expertise accumulated in Israel and around the world. The company was founded by former senior officials of Israeli security and senior experts of the high-tech industry.

The company's first advanced line of product, COGITO, is designed to identify malicious intent in various settings and scenarios. The technical solution is comprised of a front-end, the Test Station, and a back-office where multiple-station and multiple-site data is stored, managed and distributed. In a 5 minute test, the system can identify terrorists, employees who have hostile intents, criminals, smugglers or collaborators and direct further interrogation.

The military grade COGITO1003 is a fully automated, stationary "Internal Threat" and Pre Employment and employee integrity screening system. This technology was successfully tested by U.S. Governmental Agencies, Israeli Security agencies and is currently being used by both commercial and governmental customers in Israel, Mexico, India, South Africa and some former Soviet Union countries.

Suspect Detection Systems Inc. aims to assist law enforcement agencies all over the world as they fight against local and international sophisticated organized crime and terrorism. Leveraging its advanced technology and team of experienced professionals, the company provides innovative solutions that can be deployed today to protect the security of tomorrow. Disclaimer

Suspect Detection Systems Company Blog

Suspect Detection Systems News:

Suspect Detection Systems Inc. Announces Introduction of Commercial Cogito Data Center Knowledgebase

Suspect Detection Systems Inc. Announces Sale of Cogito Crime Prevention Technology to Federal Agency in India

Suspect Detection Systems Inc. Completes Sale of Cogito Interrogation Technology to Private Diamond Enterprise in Africa

Consorteum Holdings, Inc. (CSRH) Links Customers and Clients Together

Consorteum Holdings, Inc. is a company in a great position to bring together clients and customers, a service more needed now than perhaps ever before. Consorteum uses sophisticated card technologies to develop loyalty programs and other customer motivators that help its clients bring in new customers and keep existing customers. Its solutions can be applied to virtually any consumer oriented industry, and can make a major difference to a client’s bottom line.

The company’s latest move is called My Golf Rewards, actually a joint venture partnership company put together with Innovative Loyalty Solutions and Score Golf Magazine. The new company is set up to provide loyalty and retention programs for member golf courses, first in Canada and then throughout North America and beyond. Participating golf courses give out My Golf Rewards membership cards to interested golfers, who can then use them to gain discounts and other rewards. The program attracts new golfers, and helps hold on to current members, resulting in tens of thousands of dollars in additional annual revenue for participating golf courses.

The mechanics of the system is fairly simple, and easier to manage and track than complex discount programs. As golf services are used, loyalty dollars/points are credited to a golfer’s loyalty account via the card. The points can be redeemed for another round of golf or related services. The golfer is motivated to be more active, while the golf course gains value in two ways:

• Retail operations at the course have the option to give additional discounts and money back to the card whenever a golfer spends money at the store, encouraging golfers to spend more at the store.
• Cards can be used to track and collect data on golfer spending habits, which can later be used for individually targeted marketing campaigns.

The system is easy for golf courses to get into and use, with a flexible software interface that supports significant scale up with minimal costs. It also allows the industry to grow from the inside, benefitting both golf courses and users.

Sector 10 Inc. (SECI) Aims to Be Industry “First” with Unique Emergency Response Units

Sector 10 Inc. is a systems integration sales and marketing company for a line of proprietary products and technologies developed and manufactured by Sector 10 Holdings Inc. Its mission is to become the world’s leading provider of emergency life response equipment.

The company’s response products include mobile (MRU) and stationary (SRU) response units, as well as an emergency communications system designed to save lives and avert injuries in the middle of emergency and disaster situations. To fulfill its goal of becoming an industry leader, the company balances its short-term performance with long-term goals to be the “first” in its industry, focusing on the integration of humanitarian aid and technology and products.

Sector 10’s SRUs provide responders and building occupants with first aid supplies, life saving equipment and tracking devices available through a real-time 3D interface. The units can be placed near stairways, elevators or other areas that may experience high-volume foot traffic in disasters. The units are equipped with an eye wash system, an integrated computer system, a visual touch screen panel that provides instructions and feedback, and other various options.

MRUs provide mobility and customization to first responders at a disaster site and are equipped with an eye wash system, integrated computer system, Wi-Max wireless technology, first aid supplies and doors that convert into a stretcher, table and bench, and other relevant features.

CytRx Corp. (CYTR) Awarded Positive Opinion from European Medicines Agency for Leukemia Drug Candidate

CytRx Corp. is a biopharmaceutical research and development company focused on the development of high-value human therapeutics. Its current development pipeline includes programs in clinical development for cancer indications, including its lead drug candidate tamibarotene, for the treatment of acute promyelocytic leukemia (APL).

The company today announced that tamibarotene has received an official positive opinion from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency. The opinion now sits before the European Union (EU) commission for final approval and publication in the community register.

The company has already secured Orphan Drug Designation for APL and Fast Track Designation of tamibarotene by the U.S. Food and Drug Administration (FDA) in October of 2007. Steven A. Kriegsman, CytRx president and CEO, said COMP’s review and opinion of the drug candidate validates tamibarotene’s value in the marketplace.

“We believe that the positive opinion by the COMP reflects the potential therapeutic value of tamibarotene as a treatment for European patients suffering from APL, especially for those who currently lack an effective third-line therapy for their disease. We consider this positive opinion important as it supports our ability to pursue marketing approval for tamibarotene in the EU in addition to our ongoing U.S. clinical program,” Kriegsman stated in the press release. According to the company, the positive opinion will allow it to move forward with EU regulations and puts it one step closer to gaining EU marketing approval.

“The granting of orphan medicinal product status for tamibarotene will provide us with an improved communications mechanism with the European Medicines Agency (EMEA) and other EU regulatory officials going forward as we pursue EU approval. Added interaction between the EMEA and CytRx during the regulatory process could assist us in obtaining marketing approval for tamibarotene for the treatment of APL in the EU,” CytRx chief scientific officer Jack Barber, Ph.D., stated in the press release.

Similar to the FDA’s orphan drug grants, the European Commission grants orphan medicinal product status for drugs used to prevent or diagnose diseases or conditions. The European Commission grants such approval to promote innovation in the development of treatments for diseases that affect no more than five in 10,000 persons in the EU.
If CytRx is successful in getting orphan drug grant from the commission, the company will have exclusive marketing rights of tamibarotene in the EU for 10 years, as long as it also gets marketing approval.


Daily Video
Get the latest market news every weekday at 11am EST with QualityStocks.net anchors Cathy Rankin, Vanessa Ramirez and Jenn Hoffman.

Sponsors of the Day


The QualityStocks Public Company Sponsor News


QualityStocks By The Numbers Report




About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-308-0703